Company Filing History:
2 out of 151 
1 out of 2 Years Active: 2016-2019
Title: Birgit Schafer: Innovator in Viral Vector Technology
Introduction
Birgit Schafer is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of immunology, particularly in the development of recombinant viral vectors aimed at inducing immune responses to influenza A viruses. With a total of two patents to her name, her work is paving the way for advancements in vaccine technology.
Latest Patents
Birgit Schafer's latest patents focus on recombinant viral vectors and methods for inducing a heterosubtypic immune response to influenza A viruses. The inventions relate to the use of recombinant viral vectors, such as the non-replicating modified vaccinia virus Ankara. These vectors are designed to be cross-protective, providing a means to induce heterosubtypic immunity against various strains of influenza A viruses.
Career Highlights
Throughout her career, Birgit has worked with notable companies, including Baxalta GmbH and Ology Bioservices Inc. Her expertise in viral vector technology has positioned her as a key player in the field of immunology and vaccine development.
Collaborations
Birgit has collaborated with esteemed colleagues, including Falko-Günter Falkner and P. Noel Barrett. These partnerships have further enhanced her research and contributions to the scientific community.
Conclusion
Birgit Schafer's innovative work in recombinant viral vectors represents a significant advancement in the fight against influenza A viruses. Her patents and collaborations highlight her dedication to improving public health through scientific research.